@prefix adms: <http://www.w3.org/ns/adms#> .
@prefix au: <http://www.w3.org/2015/03/inspire/au#> .
@prefix bc: <https://ontology.bommaritollc.com/vocab/core/> .
@prefix bcgeo: <https://ontology.bommaritollc.com/vocab/geo/> .
@prefix bcleg: <https://ontology.bommaritollc.com/vocab/leg/> .
@prefix bcorg: <https://ontology.bommaritollc.com/vocab/org/> .
@prefix bcsec: <https://ontology.bommaritollc.com/vocab/sec/> .
@prefix bcweb: <https://ontology.bommaritollc.com/vocab/web/> .
@prefix dcat: <http://www.w3.org/ns/dcat#> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix eli: <http://data.europa.eu/eli/ontology#> .
@prefix geo: <http://www.opengis.net/ont/geosparql#> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix opengov: <http://www.w3.org/ns/opengov#> .
@prefix org: <http://www.w3.org/ns/org#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix pav: <http://purl.org/pav/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix semapv: <https://w3id.org/semapv/vocab/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix skosxl: <http://www.w3.org/2008/05/skos-xl#> .
@prefix sssom: <https://w3id.org/sssom/> .
@prefix time: <http://www.w3.org/2006/time#> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://ontology.bommaritollc.com/id/01a0f0b0-672a-751b-867f-e5e29320f75c> eli:cites <https://ontology.bommaritollc.com/id/01a0edf4-5b27-7466-a019-fef93b12cea0>, <https://ontology.bommaritollc.com/id/01a0f085-3c9f-719c-b57c-b49468549a23>, <https://ontology.bommaritollc.com/id/01a0f0af-ca2e-7002-b2a9-099bcc994109>, <https://ontology.bommaritollc.com/id/01a0f0b0-52fb-7435-bf0d-42267efce642> ;
    a schema:Legislation ;
    skos:prefLabel "40 CFR 795.232 Inhalation and dermal pharmacokinetics of commercial hexane."@en ;
    adms:identifier <https://ontology.bommaritollc.com/id/01a0f0b0-672b-74b3-b84f-398caa6c125d> ;
    prov:wasDerivedFrom <https://ontology.bommaritollc.com/id/01a0f0b0-672a-751b-867f-e5e1aad0cf16>, <https://ontology.bommaritollc.com/id/01a0f0b0-b742-765a-98b3-df26c6c4a7e7>, <https://ontology.bommaritollc.com/id/01a0f0d1-8808-7729-8adc-d33bba61ba4a>, <https://ontology.bommaritollc.com/id/01a10f17-f35a-76fe-9889-f1bb24e0ef85> ;
    schema:isPartOf <https://ontology.bommaritollc.com/id/01a0f0af-c531-7246-9532-a96dcddce940> ;
    schema:legislationIdentifier "40 CFR 795.232" ;
    schema:legislationJurisdiction <https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0> ;
    schema:legislationLegalForce schema:InForce ;
    schema:legislationType bcleg:cfrSection ;
    schema:name "Inhalation and dermal pharmacokinetics of commercial hexane"@en ;
    schema:url <https://www.govinfo.gov/link/cfr/40/795?sectionnum=232&year=mostrecent&link-type=details> .
